Clinical Trials in Nebraska
Nebraska ranks #34 nationally by clinical-trial count, with 94 trials listed, all currently recruiting.
Among trials with a recorded phase, Phase 3 is the largest group at 27 trials.
The top conditions by trial volume are Peripheral Arterial Disease (4), Multiple Myeloma (3), Rheumatoid Arthritis (3).
94
Total Trials
94
Recruiting
#34
National Rank
15
Conditions
Trials by Phase
25
Not Applicable
8
Phase 1 / Phase 2
5
Phase 2 / Phase 3
1
Early Phase 1
11
Phase 1
12
Phase 2
27
Phase 3
5
Phase 4
Top Conditions in Nebraska
Top Sponsors in Nebraska
Cities With Most Trials in Nebraska
| # | City | Trials |
|---|---|---|
| 1 | Omaha | 77 |
| 2 | Lincoln | 12 |
| 3 | Grand Island | 3 |
| 4 | Papillion | 3 |
| 5 | Bellevue | 2 |
| 6 | Norfolk | 1 |
| 7 | North Platte | 1 |
Important: This information is for research purposes only. Always talk to your doctor about whether a clinical trial is right for you.
Frequently Asked Questions
Nebraska currently has 94 clinical trials actively recruiting participants, making it #34 nationally by total trial count.
The most-studied conditions in Nebraska are Peripheral Arterial Disease (4 trials), Multiple Myeloma (3 trials), Rheumatoid Arthritis (3 trials).
Browse the conditions listed on this page to find trials recruiting in Nebraska. Each condition page shows trial details, eligibility criteria in plain English, and contact information. Always talk to your doctor about whether a trial is right for you.
Trial counts reflect currently recruiting studies listed on ClinicalTrials.gov with locations in this state.
Source: ClinicalTrials.gov, 2026.